Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Feb 28 2020

Full Issue

Report Uncovers Bloomberg's Helpful PR Role When Billionaire Sackler Family Was Under Fire For Opioid Crisis

The ProPublica report details the friendship between Michael Bloomberg and Mortimer Sackler and efforts taken to kill a Bloomberg Businessweek story on the Sackler's role in the crisis. News on the epidemic is from Pennsylvania, also.

ProPublica: When The Billionaire Family Behind The Opioid Crisis Needed PR Help, They Turned To Mike Bloomberg

Long celebrated as civic-minded philanthropists, the Sacklers were becoming pariahs. The billionaire family whose company created and pushed the addictive painkiller OxyContin had managed to escape connection with the opioid crisis for years, but now two magazine pieces were portraying them as pain profiteers. Museums that had sought their donations were being asked about giving the money back. Mortimer D.A. Sackler — son of a co-founder of the company, Purdue Pharma, and a member of its board — was openly furious. (Dreier, 2/28)

The Associated Press: US Supervised Injection Site Put On Hold Amid Opposition

Plans to open what could be the nation's first medically supervised injection site in Philadelphia were put on hold Thursday night amid strenuous opposition from a federal prosecutor and residents of the neighborhood where it would have been located. Mayor Jim Kenney said that Safehouse agreed to push back its opening date so it can meet with members of the community and hear their concerns. Meanwhile, the owner of the medical complex in south Philadelphia where Safehouse planned to operate its first injection site abruptly pulled out, leaving the project in limbo. (2/27)

The Wall Street Journal: First Sanctioned Supervised Drug Site In U.S. Hits Another Snag

“Now that the landlord has decided to not go forward with the lease, we need to do a little regrouping and assess our options,” she said. Just a day earlier, a favorable court ruling led Safehouse to announce plans to open its first location next week. The nonprofit has been battling in court with the local U.S. attorney’s office, but a federal judge sided with Safehouse’s argument that its operation wouldn’t violate the law. The U.S. attorney has launched an appeal. (Kamp, 2/27)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF